Carissa Kicinski, PA
Physician Assistant · Raleigh, NCNPI 1992240741
Payments from drug & device makers
Across 171 payments — averaging $13.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$568
- Alkermes, Inc.$407
- AbbVie$311
- Otsuka America Pharmaceutical, Inc.$256
- Lundbeck LLC$126
- Vanda Pharmaceuticals Inc.$125
- plus $542 from 11 others
What the payments were for
- Food & beverage$2,332100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 66 | $568 |
| Alkermes, Inc. | 20 | $407 |
| AbbVie(2 entities) | 23 | $311 |
| Otsuka America Pharmaceutical, Inc. | 14 | $256 |
| Lundbeck LLC | 5 | $126 |
| Vanda Pharmaceuticals Inc. | 8 | $125 |
| Teva Pharmaceuticals USA, Inc. | 8 | $123 |
| Sunovion Pharmaceuticals Inc. | 8 | $110 |
| Neurocrine Biosciences, Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $55 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
| Johnson & Johnson | 2 | $36 |
| Avanir Pharmaceuticals, Inc. | 2 | $33 |
| Eisai Inc. | 2 | $31 |
| USWM, LLC | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
How this compares
$2,335 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 81 | $133,013 |
| Austedo XrDeutetrabenazine | 16 | $101,006 |
| RexultiBrexpiprazole | 46 | $73,679 |
| CaplytaLumateperone Tosylate | 38 | $66,101 |
| Invega SustennaPaliperidone Palmitate | 18 | $57,039 |
| AristadaAripiprazole Lauroxil | 13 | $42,971 |
| FanaptIloperidone | 12 | $26,462 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 173 | $18,620 |
| TrintellixVortioxetine Hydrobromide | 13 | $7,004 |
| BelsomraSuvorexant | 15 | $6,608 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $6,463 |
| Adderall XrDextroamphetamine/Amphetamine | 27 | $5,651 |
| Aripiprazole | 184 | $5,448 |
| Lurasidone Hcl | 83 | $4,018 |
| Oxcarbazepine | 34 | $3,281 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $311 | $133,01381 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $123 | $101,00616 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $256 | $73,67946 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $568 | $66,10138 claims |
| Johnson & JohnsonInvega Sustenna | $36 | $57,03918 claims |
| Alkermes, Inc.Aristada | $407 | $42,97113 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $125 | $26,46212 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $55 | $7,00413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Raleigh
- Jessica CainRaleigh$77K
- Carrie McGroartyRaleigh$69K
- Jaime BullRaleigh$25K
- Kristina KohuthRaleigh$24K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.